Can-Fite BioPharma (CANF) Debt Ratio (2014)
Can-Fite BioPharma (CANF) posted Debt Ratio of 0.67 for Q4 2014.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Debt Ratio (2014) Analysis & Trends
Can-Fite BioPharma (CANF) has 1 years of Debt Ratio data on file, last reported at 0.67 in Q4 2014.
- For the quarter ending Q4 2014, Debt Ratio changed N/A year-over-year to 0.67; the trailing twelve-month figure through Dec 2014 stood at 0.67 (changed N/A YoY), and the FY2014 full-year result was 0.67, changed N/A from the prior year.
- Debt Ratio was 0.67 for Q4 2014 at Can-Fite BioPharma.
- In the past five years, Debt Ratio ranged from a high of 0.67 in Q4 2014 to a low of 0.67 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.77 Bn | 631.01 Bn | 17.26 Bn | 0.30 |
| 2 | AbbVie | 447.56 Bn | 440.99 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 364.58 Bn | 357.44 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 268.98 Bn | 261.29 Bn | 11.24 Bn | 0.08 |
| 5 | Pfizer | 158.03 Bn | 146.33 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.29 Bn | 44.91 Bn | 10.79 Bn | 0.17 |
| 7 | Revolution Medicines | 43.18 Bn | 43.18 Bn | - | - |
| 8 | Incyte | 25.12 Bn | 20.58 Bn | 1.57 Bn | 0.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Can-Fite BioPharma | 1.83 Mn | -1.16 Mn | - | - |